SynDaver
PrivateLast Round
Seed
Jul 29, 2015
Total Funding Raised
$1.55M
Company Overview
SynDaver is a manufacturing company that produces synthetic human and animal tissues and body parts intended to replace live animals, cadavers, and human patients in medical device studies, clinical training, and surgical simulation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Defense Tech, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynDaver Comparables
Compare SynDaver with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Simulab Corporation | 86% | |
| Operative Experience | 85% | |
| SurgiReal Products, Inc. | 82% | |
SynDaver Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 29, 2015 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 13, 2025
Monthly visitors increased 43% MoM.
- Jul 2, 2025
Monthly visitors grew 179% MoM, reaching 18.4K.
SynDaver Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SynDaver's valuation, stock price, and market status.